Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M51.8Revenue $M3.3Net Margin (%)-803.8Altman Z-Score-24.7
Enterprise Value $M29.1EPS $-0.4Operating Margin %-1,190.0Piotroski F-Score2
P/E(ttm)--Beneish M-Score-3.8Pre-tax Margin (%)-803.8Higher ROA y-yY
Price/Book4.310-y EBITDA Growth Rate %-38.0Quick Ratio1.9Cash flow > EarningsN
Price/Sales14.85-y EBITDA Growth Rate %-21.9Current Ratio1.9Lower Leverage y-yN
Price/Free Cash Flow--y-y EBITDA Growth Rate %--ROA % (ttm)-64.9Higher Current Ratio y-yY
Dividend Yield %--PEG--ROE % (ttm)-208.2Less Shares Outstanding y-yN
Payout Ratio %--Shares Outstanding M75.5ROIC % (ttm)--Gross Margin Increase y-yN

Gurus Latest Trades with SNSS

Number of guru portfolios checked: 68.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
SNSSFirst Eagle Investment 2015-06-30 Sold Out $2.07 - $3.01
($2.53)
$ 0.69-73%Sold Out0
SNSSFirst Eagle Investment 2015-03-31 Reduce-0.01%$2.1 - $2.83
($2.4)
$ 0.69-71%Reduce -58.43%587,976
SNSSFirst Eagle Investment 2014-12-31 Buy 0.01%$1.05 - $6.64
($2.06)
$ 0.69-67%New holding1,414,276
SNSSFirst Eagle Investment 2014-09-30 Sold Out $5.553 - $8.23
($6.91)
$ 0.69-90%Sold Out0
SNSSFirst Eagle Investment 2013-09-30 Buy $4.55 - $6.05
($5.08)
$ 0.69-86%New holding200,000
SNSSFirst Eagle Investment 2013-03-31 Sold Out -0.01%$4 - $6.49
($5.21)
$ 0.69-87%Sold Out0
SNSSFirst Eagle Investment 2012-09-30 Reduce$2.95 - $5.76
($3.55)
$ 0.69-81%Reduce -30.24%350,000
SNSSFirst Eagle Investment 2012-06-30 Buy 0.01%$2.51 - $3.18
($2.78)
$ 0.69-75%New holding501,727
SNSSFirst Eagle Investment 2009-12-31 Sold Out $1.8 - $12.54
($3.76)
$ 0.69-82%Sold Out0
SNSSFirst Eagle Investment 2009-06-30 Reduce$0.99 - $3.45
($1.95)
$ 0.69-65%Reduce -90.60%16,667
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

SNSS is held by these investors:

No Entry found in the selected group of Gurus. You can
Premium Most recent portfolio changes are included for Premium Members only!


SNSS: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Misfeldt DaytonDirector 2015-12-21Buy1,750,000$0.84-17.86view
Swisher Daniel N JRPresident and CEO 2015-08-25Buy25,000$1.01-31.68view
Ketchum Steven BDirector 2015-07-24Sell6,358$3.46-80.06view
BJERKHOLT ERICEVP, CFO & Corp. Secretary 2015-07-24Sell6,358$3.46-80.06view
Swisher Daniel N JRPresident and CEO 2015-07-24Sell12,715$3.46-80.06view
BAY CITY CAPITAL LLC10% Owner 2015-07-24Sell635,702$3.46-80.06view
Misfeldt DaytonDirector 2015-07-24Sell635,702$3.46-80.06view
BARRIS PETER J10% Owner 2014-08-29Sell266,700$7.97-91.34view
BARRETT M JAMES10% Owner 2014-08-29Sell266,700$7.97-91.34view
Growth Equity Opportunities Fu10% Owner 2014-08-29Sell266,700$7.97-91.34view

Quarterly/Annual Reports about SNSS:

News about SNSS:

Articles On GuruFocus.com
Roundys Among Largest Insiders' Buys of the Week Dec 31 2015 
Sunesis Pharmaceuticals Inc. Reports Operating Results (10-Q) Nov 04 2010 
Weekly CFO Buys Highlight: SNSS, INUV, CEP, CMTL, SURW Oct 09 2010 
Sunesis Pharmaceuticals Inc. Reports Operating Results (10-Q) Aug 13 2010 
Sunesis Pharmaceuticals Inc. Reports Operating Results (10-Q) Apr 29 2010 
Hardest Hit Companies of the Day: Transition Therapeutics Inc., Sunesis Pharmaceuticals Inc., GenCor Dec 15 2009 
Most Trade Guru Stocks: Citigroup Inc., Bank of America Corp., Alcoa Inc., Sunesis Pharmaceuticals Dec 12 2009 
Sunesis Pharmaceuticals Inc. Reports Operating Results (10-Q) Nov 16 2009 
Sunesis Pharmaceuticals Inc. Reports Operating Results (10-Q) Jul 28 2009 
Sunesis Pharmaceuticals Inc. Reports Operating Results (10-Q) May 08 2009 

More From Other Websites
Edited Transcript of SNSS earnings conference call or presentation 5-Nov-15 4:00pm GMT Jan 08 2016
Sunesis Pharmaceuticals Announces European Medicines Agency Validates Marketing Authorization... Jan 04 2016
Sunesis Pharmaceuticals Announces European Medicines Agency Validates Marketing Authorization... Jan 04 2016
Will Sunesis Pharmaceuticals (SNSS) Continue to Surge Higher? Dec 24 2015
Sunesis Announces Closing of $26 Million Offering of Securities and Exercise of Underwriter’s... Dec 21 2015
SUNESIS PHARMACEUTICALS INC Files SEC form 8-K, Other Events, Financial Statements and Exhibits Dec 21 2015
Sunesis Announces Closing of $26 Million Offering of Securities and Exercise of Underwriter’s... Dec 21 2015
Sunesis Pharmaceuticals, Inc. Earnings Analysis: Q3, 2015 By the Numbers Dec 17 2015
SUNESIS PHARMACEUTICALS INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Material... Dec 16 2015
Sunesis Announces Pricing of $25 Million Offering of Securities Dec 16 2015
Sunesis Announces Pricing of $25 Million Offering of Securities Dec 16 2015
SUNESIS PHARMACEUTICALS INC Financials Dec 08 2015
Sunesis Pharmaceuticals Announces Submission of a Marketing Authorization Application for Vosaroxin... Dec 08 2015
Sunesis Pharmaceuticals Announces Submission of a Marketing Authorization Application for Vosaroxin... Dec 08 2015
Sunesis Pharmaceuticals Announces Presentation of Positive Results From MD Anderson Sponsored Trial... Dec 07 2015
Sunesis Pharmaceuticals Announces Presentation of Positive Results From MD Anderson Sponsored Trial... Dec 07 2015
Sunesis Pharmaceuticals Announces Presentation of Results From Washington University Sponsored Phase... Dec 06 2015
Sunesis Pharmaceuticals Announces Presentation of Results From Washington University Sponsored Phase... Dec 06 2015
Sunesis Partners With Clinigen Group to Initiate a Compassionate Use Program for Patients With... Dec 03 2015
Sunesis Partners With Clinigen Group to Initiate a Compassionate Use Program for Patients With... Dec 03 2015

Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.

User Comments

No comment yet
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK